Patents Assigned to Aarhus University
  • Labeled oxytocin and method of manufacture and use
    Patent number: 11970554
    Abstract: Disclosed are 13N-oxytocin molecules, methods of manufacture of 13N-oxytocin molecules and methods of use of 13N-oxytocin molecules in the determination of the distribution and kinetics of 13N-oxytocin molecules after craniofacial or other application methods.
    Type: Grant
    Filed: March 1, 2019
    Date of Patent: April 30, 2024
    Assignees: TONIX PHARMACEUTICALS HOLDING CORP., AARHUS UNIVERSITY
    Inventors: Steen Jakobsen, Michael Winterdahl, Erik Nguyen Nielsen, David C. Yeomans, Dean Carson
  • EGFR blood monitoring
    Patent number: 9914975
    Abstract: Improved methods of assessing status of a solid-tumor cancer in a subject involving detection of tumor-associated mutations in the subject's blood.
    Type: Grant
    Filed: April 13, 2016
    Date of Patent: March 13, 2018
    Assignees: Roche Molecular Systems, Inc., Aarhus University
    Inventors: Peter Meldgaard, Boe Sorensen, Julie Tsai, Wei Wen, Lin Wu
  • Agents, uses and methods
    Patent number: 9724426
    Abstract: The present invention relates to agents comprising a binding moiety with binding specificity for SRCR domain 1 of the CD163 receptor, for use in medicine. The invention also relates to methods, uses, kits and compositions comprising such agents.
    Type: Grant
    Filed: September 29, 2010
    Date of Patent: August 8, 2017
    Assignees: AFFINICON APS, AARHUS UNIVERSITY HOSPITAL
    Inventors: Niels Jonas Heilskov Graversen, Pia Svendsen, Peter Astrup Christensen, Maciej Bogdan Maniecki, Søren Kragh Moestrup, Holger Jon Møller, Gabriele Anton
  • An Optical Waveguide Comprising A Core Region With Integrated Hologram
    Publication number: 20150369985
    Abstract: An optical waveguide comprising an axial direction and a cross-section perpendicular to said axial direction is shown. The optical waveguide comprises a core region. The core region includes an integrally formed hologram, which extends along a first axial segment of the optical waveguide, the first axial segment having a first axial length. The hologram, seen in the cross-section, includes a micro-structure with written elements having a modified refractive index different from areas of the core region with an unmodified refractive index.
    Type: Application
    Filed: January 27, 2014
    Publication date: December 24, 2015
    Applicant: AARHUS UNIVERSITY
    Inventors: Lars Gruner-Nielsen, Peter Balling, Juha-Matti Savolainen, Poul Kristensen
  • STRESS-TOLERANT PLANTS EXPRESSING MANNOSYLGLYCERATE-PRODUCING ENZYMES
    Publication number: 20120117686
    Abstract: The present invention provides compositions and methods for increasing the level of mannosylglycerate in plants. Plants with increased levels of mannosylglycerate exhibit enhanced tolerance to stress, e.g., drought.
    Type: Application
    Filed: May 4, 2010
    Publication date: May 10, 2012
    Applicants: THE REGENTSOF THE UNIVERSITY OF CALIFORNIA, AARHUS UNIVERSITY, UNIVERSITY OF COPENHAGEN
    Inventors: Henrik Vibe Scheller, Jesper Harholt, Peter Ulvskov
  • Nod-factor perception
    Patent number: 7915485
    Abstract: The present invention provides a Nod-factor binding element, comprising one or more NFR polypeptides encoded by NFR genes, that are useful for providing non-nodulating plants with Nod-factor binding properties and triggering the endosymbiotic signalling pathway leading to nodulation. Furthermore the invention is useful for breeding for improved nodulation in nodulating legumes.
    Type: Grant
    Filed: July 2, 2004
    Date of Patent: March 29, 2011
    Assignee: Aarhus University
    Inventors: Jens Stougaard Jensen, Lene Heegaard Madsen, Elena Simona Radutoiu, Esben Bjorn Madsen, Niels Norgaard Sandel
  • METHODS AND PREPARATIONS FOR CURING CRITICALLY ILL PATIENTS
    Publication number: 20090181882
    Abstract: The present invention pertains to the use of a blood mannan-binding lectin (MBL) regulator for the manufacture of a life saving drug to treat or cure a critically ill patient. It further involves the use of measurements of MBL to predict mortality in critically ill ICU patients. One further aspect of present invention is to the use of monomers and oligomers of MBL in prophylactic and/or curative treatment of patients admitted to intensive care units (ICUs).
    Type: Application
    Filed: December 30, 2008
    Publication date: July 16, 2009
    Applicants: K.U. Leuven Research and Development, Aarhus Universitet, Aarhus University Hospital
    Inventors: Greta Van Den Berghe, Steffen Thiel, Troels Krarup Hansen
  • Nod-Factor Perception
    Publication number: 20080172763
    Abstract: The present invention provides a Nod-factor binding element, comprising one or more NFR polypeptides encoded by NFR genes, that are useful for providing non-nodulating plants with Nod-factor binding properties and triggering the endosymbiotic signalling pathway leading to nodulation. Furthermore the invention is useful for breeding for improved nodulation in nodulating legumes.
    Type: Application
    Filed: July 2, 2004
    Publication date: July 17, 2008
    Applicant: Aarhus University
    Inventors: Jens Stougaard Jensen, Lene Heegaard Madsen, Elena Simona Radutoiu, Esben Bjorn Madsen, Niels Norgaard Sandel
  • Methods and preparations for curing critically ill patients
    Publication number: 20060122102
    Abstract: The present invention pertains to the use of a blood mannan-binding lectin (MBL) regulator for the manufacture of a life saving drug to treat or cure a critically ill patient. It further involves the use of measurements of MBL to predict mortality in critically ill ICU patients. One further aspect of present invention is to the use of monomers and oligomers of MBL in prophylactic and/or curative treatment of patients admitted to intensive care units (ICUs).
    Type: Application
    Filed: September 23, 2003
    Publication date: June 8, 2006
    Applicants: K.U. Leuven Research and Development, Aarhus University Hospital
    Inventors: Greta Van Der Berghe, Steffen Thiel, Troels Hansen
  • Expression of heterologous genes from an IRES translational cassette in retroviral vectors
    Patent number: 7056730
    Abstract: The present invention relates to a retroviral vector which expresses a gene, e.g. for therapeutic use and/or of viral origin, under the translational control of an internal ribosomal entry site (IRES) resulting in the efficient translation of said gene.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: June 6, 2006
    Assignee: Aarhus University
    Inventors: Finn Skou Pedersen, Thomas Jesperson, Mogens Duch
  • Expression of heterologous genes from an IRES translational cassette in retroviral vectors
    Publication number: 20030157718
    Abstract: The present invention relates to a retroviral vector which expresses a gene, e.g. for therapeutic use and/or of viral origin, under the translational control of an internal ribosomal entry site (IRES) resulting in the efficient translation of said gene.
    Type: Application
    Filed: October 26, 2001
    Publication date: August 21, 2003
    Applicant: AARHUS UNIVERSITY
    Inventors: Finn Skou Pedersen, Thomas Jesperson, Mogens Duch
  • Building
    Patent number: D845507
    Type: Grant
    Filed: July 7, 2015
    Date of Patent: April 9, 2019
    Assignee: FACULTY OF HEALTH, AARHUS UNIVERSITY
    Inventor: Jan Hejle